LXRX
Lexicon Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.24
−0.88%Margins
Gross margin
98.9%
EBITDA margin
-126.0%
EBIT margin
-131.4%
Net margin
-147.4%
FCF margin
-192.2%
-35.0%
Return on equity
-24.4%
Return on assets
-23.3%
Return on invested capital
0.16x
Asset turnover
-$79.7M
Cash from operations
$0.43
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026